Skip to main content
OpenTrials
Completed

NCT Number: NCT02821065

Telehealth for Emergency-Community Continuity of Care Connectivity Via Home-Telemonitoring

Modern technology like computers, smartphones and the Internet enable patients to measure certain health indicators, like blood pressure and body weight, from the comfort of their own homes. This information can also be shared electronically with doctors and other healthcare providers to monitor remotely. This is called home health monitoring. In TEC4Home, we are developing a home monitoring solution for patients with heart failure to support their care and recovery at home after a visit to the emergency department. We hope to show that this solution decreases revisits to the emergency department and increases quality of life for patients.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

PATIENT PARTICIPANTS:

  • Have one or more typical symptoms of Heart Failure (i.e. dyspnoea at rest or minimal exertion (includes orthopnoea, reduced exercise tolerance)) AND
  • Have one or more typical signs of Heart Failure (i.e. elevated jugular venous pressure, pulmonary crepitations, pleural effusions, peripheral oedema) AND
  • Have one or more objective measures of heart failure:

Radiological congestion.

  • Elevated BNP ≥ 400 pg/mL or NT-proBNP ≥ 1000 pg/mL.
  • Reduced left ventricular ejection fraction <40% (or <45%) in previous 12 months.

Diastolic dysfunction including tissue Doppler E/e' ratio > 15 in previous 12 months.

  • Pulmonary capillary wedge pressure >20 mmHg.
  • Diuretic therapy. The additional value of diuretic therapy (IV or oral) is debatable, as presumably unlikely (or unsafe) that patient with genuine HF will be discharged without diuretic.

CLINICIAN PARTICIPANTS:

To be eligible to participate, clinician participants (i.e. ED physicians, family physicians and monitoring nurse(s)) must have referred or have a patient enrolled in the TEC4Home monitoring service.

Exclusion criteria

PATIENT PARTICIPANTS:

  • Physical barriers e.g. unable to stand on scales.
  • Cognitive impairment (e.g. MMSE <20), unless suitable caregiver support.
  • Language (must be able to read and understand English), unless suitable caregiver support.
  • Documented history of current and active substance misuse (within 3 months).
  • Lack digital connectivity or landline phone connection.
  • No regular care provider e.g. GP, or at least regular walk-in clinic.
  • Existing intensive system of care: LVAD, transplant, dialysis.
  • Anticipated improvement due to revascularization (PCI/CABG) or valve intervention during index hospitalization.
  • Anticipated survival <90 days. Active palliative care, less-than level III care, disseminated malignancy.

CLINICIAN PARTICIPANTS:

Clinicians who do not have patients enrolled in the TEC4Home service or who themselves are not involved in the implementation or operation of the TEC4Home monitoring service will not be eligible to participate.

Treatment and study plan

Remote Patient Monitoring

Device

Primary outcomes

  1. Change in number of emergency department revisits 90 day pre and 90 days post enrollment.

    Time frame: 90 days

    Hospital administrative data and self-reported data will be reviewed to assess the number of emergency department visits 90 day pre and 90 days post enrollment.

  2. Change in the number of hospitalizations

    Time frame: 90 days

    Hospital administrative data and self-report data will be reviewed to assess the number of hospitalizations 90 day pre and 90 days post enrollment.

  3. Change in the length of stay (in days)

    Time frame: 90 days

    Hospital administrative data and self-report data will be reviewed to assess the length of stay (measured in days) 90 day pre and 90 days post enrollment.

  4. Mortality rate

    Time frame: 90 days

    The number of patients who pass away during the 90 day follow-up period will be recorded.

Secondary outcomes

  1. Difference in quality of life (HF-specific) scores as assessed by the Kansas City Cardiomyopathy Questionnaire 12 (KCCQ-12) scale

    Time frame: 90 days

    A 12 item disease-specific quality of life questionnaire will be administered to all participants for comparison pre-post enrollment.

  2. Difference in quality of life (general) scores as assessed by the VR-12

    Time frame: 90 Days

    A generic health-related quality of life questionnaire to be administered to all participants for comparison pre to post enrollment.

  3. Difference in self-care efficacy scale scores as assessed by the European Heart Failure Self-care Behaviour Scale

    Time frame: 90 Days

    A 9 item scale to asses a patient's self-care behaviours and attitudes specific to Heart Failure will be administered to all participants for comparison pre-post enrollment.

  4. Difference in costs and savings via administrative data and a self-report healthcare utilization survey.

    Time frame: 90 days

    Costs related to healthcare utilization and other health-related out of pocket and system costs will be assessed and compared 90 days pre to 90 days post enrollment

  5. Impact of patient experience of care via surveys

    Time frame: 90 days

    Feedback from patients via survey questions to understand their experiences using the home health monitoring technology.

  6. Impact of patient experience of care via interviews

    Time frame: 90 days

    Feedback from patients via interview questions to understand their experiences using the home health monitoring technology.

  7. Impact on communication between healthcare providers and patients via surveys

    Time frame: 90 days

    Surveys about end-user experience will be used to collect feedback from patient participants, nurses, and other healthcare providers involved to understand the impact of home health monitoring on communication during the transition of care.

  8. Impact on communication between healthcare providers and patients via interviews

    Time frame: 90 days

    Interviews about end-user experience will be used to collect feedback from patient participants, nurses, and other healthcare providers involved to understand the impact of home health monitoring on communication during the transition of care.

Sponsors and collaborators

Lead sponsor

University of British Columbia

Other

Registry information

Official study title

TEC4Home: Telehealth for Emergency-Community Continuity of Care Connectivity Via Home-Telemonitoring

Acronym: TEC4Home

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Jul 1, 2016
Registry last updated
Mar 24, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.